{"id":"W2061870732","doi":"10.1097/spc.0b013e3283490418","title":"Current systemic management of metastatic renal cell carcinoma – first line and second line therapy","year":2011,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Hospital; Juravinski Cancer Centre; St. Joseph's Hospital","funders":"","keywords":"Temsirolimus; Medicine; Sunitinib; Sorafenib; Pazopanib; Everolimus; Renal cell carcinoma; Bevacizumab; Targeted therapy; Oncology; Systemic therapy; Clinical trial; Internal medicine; Intensive care medicine; Discovery and development of mTOR inhibitors; Cancer; PI3K/AKT/mTOR pathway; Chemotherapy; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005105345,0.0006995581,0.001622924,0.001169338,0.0002294846,0.0007185723,0.000804194,0.000772909,0.003369353],"category_scores_gemma":[0.0006099944,0.0001607474,0.0004111026,0.001108567,0.0003114078,0.0008150176,0.0003655538,0.001182384,0.002489182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005422769,"about_ca_system_score_gemma":0.0007620088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000748607,"about_ca_topic_score_gemma":0.001746715,"domain_scores_codex":[0.9998032,0.00004123393,0.00002909709,0.00002823583,0.00008232033,0.00001586868],"domain_scores_gemma":[0.9997388,0.00009337812,0.000059462,0.000007782434,0.00007416598,0.00002652691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004377304,0.00003866732,0.0001269527,0.009261117,0.00006519359,0.0002146625,0.00002430725,0.0003034837,0.0008302621,0.000831317,0.0333207,0.9549395],"study_design_scores_gemma":[0.00003941512,0.0001243233,0.001717585,0.006291729,0.0001914058,0.004766128,0.00007086642,0.000226058,0.0006637321,0.001359527,0.9845259,0.00002325466],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000140322,0.9978243,0.0001843498,0.000406356,0.0002339429,0.000005617716,0.00001351145,0.00001123957,0.001180353],"genre_scores_gemma":[0.0009461842,0.9976559,0.0002502004,0.0002695762,0.0003533955,0.000007940721,0.00003624348,0.000002154517,0.0004783865],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003369353,"threshold_uncertainty_score":0.01127166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2023019775837762,"score_gpt":0.4001937180149413,"score_spread":0.1978917404311651,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}